A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Clinical trial NCT06816264 · COMPLETED

Trial details

NCT number: NCT06816264
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment of Lipoprotein Disorder

Start date: 2025-02-18
Primary completion: 2025-09-29
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.